A study published in Stem Cell Reports demonstrates that genetically engineered human pluripotent stem cells (hPSCs) can ...

Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing novel allogeneic, or "off the shelf", cell therapies for serious medical conditions, ...

Proteomics-informed, genome-edited CHO design increased productivity up to three-fold and titers two-fold, strengthening CLD for novel biologics and biosimilars. Extended culture robustness was ...

Stem Cell Reports demonstrates that genetically engineered human pluripotent stem cells (hPSCs) can overcome immune rejection in ...

Using rodent and cellular models, the researchers showed that tanycytes take up tau from the CSF and release it into pituitary portal capillaries.

World Cancer Day 2026 – united by unique: Cell lines for national and international cancer research – Leibniz Institute DSMZ cell line collection ...

Researchers at the University of Connecticut have reported a novel bovine embryonic stem cell line with improved pluripotency and broader translational potential. The platform has opened routes ...

VINSSEN, a South Korean maritime specialist in hydrogen fuel cells and integrated system solutions, has signed a Memorandum of Understanding (MOU) with MANA Engineering, a Netherlands-based ...

Creative Biolabs, a global leader in antibody engineering, today announced its optimization of ADCC and Fc-mediated ...

A new strategy developed by Professor Nathan Gianneschi grabs cancer-driving proteins and directs them to the cell’s disposal ...

In 2024, Professor Sebastian Kobold's research group at LMU University Hospital had already shown that the metabolite prostaglandin E2 can block T cells—the killer cells of the immune system—in the ...

It’s no secret that ion-exchange membranes are the real workhorses in gadgets like fuel cell technology, batteries, and ...